BRIDGEWATER, N.J., April 13, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology company developing therapeutic candidates targeting ...
A surge in oncology drug development, coupled with increased patient access and early diagnosis, has resulted in a massive increase in global spending on cancer treatments. Due to this, the global ...
Researchers have reconstructed the ancestral relationships of the hillstream loach family tree, detailing for the first time a range of pelvic adaptations that allow some members of the fish family to ...
BRIDGEWATER, N.J., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology company developing therapeutic candidates targeting drug ...
BRIDGEWATER, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (HILS) (“Hillstream”, the “Company”) today announced the expansion of its ...
A new genetic and morphological study of South Asia's hillstream loach (Balitoridae) family is shedding new light on the fishes' unusual land-walking capabilities, including that of the family's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback